Related Experiment Video
Updated: Sep 25, 2025

Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in
Shahrzad Ossareh1, Neda Nazemzadeh, Mojgan Asgari
1Department of Medicine, Nephrology section), Iran University of Medical Sciences (IUMS), Hasheminejad Kidney Center (HKC), Tehran, Iran. ossareh_s@hotmail.com.
Insights
The presence of crescents (C) and tubular atrophy/interstitial fibrosis (T) independently predict end-stage kidney disease (ESKD) in IgA nephropathy (IgAN) patients. High risk of ESKD is associated with combined T1 and C1 scores.
Area of Science:
- Nephrology
- Pathology
- Immunology
Background:
- IgA nephropathy (IgAN) is a common glomerular disease.
- The Oxford classification (MEST score) aids prognostication.
- Crescents (C) are a recent addition to the Oxford classification.
Purpose of the Study:
- To evaluate the impact of crescents (C) on end-stage kidney disease (ESKD) development in IgAN patients.
- To assess the added prognostic value of crescents to the MEST score.
Main Methods:
- 115 IgAN patients were followed for a mean of 43 months.
- MEST score components were assessed: mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental sclerosis (S), and tubular atrophy/interstitial fibrosis (T).
- Crescents (C) were defined as C0 (absent) or C1 (present); T was defined as T0 (≤25%) or T1 (>25%).
Main Results:
- 40 patients (35%) developed ESKD.
- Crescents ≥ 30% (C1) and T1 were independently associated with increased ESKD risk (HR=3.15 and HR=7.18 respectively).
- The combined presence of T1 and C1 significantly increased ESKD risk (74% developed ESKD).
Conclusions:
- Tubular atrophy/interstitial fibrosis (T ≥ 25%) and crescents (≥ 30%) are independent predictors of ESKD in IgAN.
- The combination of T1 and C1 signifies a high risk for ESKD.
- These findings refine prognostication in IgAN patients.
Introduction:
Crescents (C) have been recently added to the Oxford classification of IgA nephropathy (IgAN) consisting of mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental sclerosis (S) and tubular atrophy/ interstitial fibrosis (T) (MEST). The aim of the study was to assess the added impact of crescents, on development of end-stage kidney disease (ESKD) in IgAN patients Methods. On-hundred fifteen IgAN patients (76% male, mean age: 37 ± 13 years, mean serum creatinine: 4.0 ± 4.3 mg/dL, mean proteinuria: 3.4 ± 2.5 g/d) were followed for 43 ± 29 months. MEST score was defined according to Oxford classification (M0/M1, E0/ E1, S0/S1). To increase the power, T was defined as T0 ≤ 25% and T1 > 25%. Crescents were defined as C0, "absence" and C1 "at least one" crescent. In sensitivity analysis, the risk of ESKD was estimated at different cut-off levels of at least 10, 20, and 30% crescents.
Results:
Forty patients (35%) developed ESKD. Among those 14% with at least one crescent, 21 patients (46%) developed ESKD. In 11 patients with C ≥ 30%, 66% and among 57 patients with T1, 60% and in 27 patients with T1 + C1 74% developed ESKD. In adjusted model, only C ≥ 30% (HR = 3.15, 95% CI: 1.15 to 11.00; P = 0.027) and the presence of T1+ C1 (HR = 7.18, 95% CI: 1.90 to 27.10, P = 0.004) were associated with increased risk of ESKD. The median kidney survival was 78.0 months (95% CI: 70.5 to 85.6 months), in patients with T0 + C0 and 32.3 months (95% CI: 19.3 to 45.3 months) in patients with T1 + C1.
Conclusion:
In this study T ≥ 25%, and the presence of crescents ≥ 30%, were independently associated with increased risk of ESKD. This risk was strongly increased in the combined presence of at least one crescent and T1 ≥ 25%, that predicted a high ESKD rate. DOI: 10.52547/ijkd.6685.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology

